AAP
GH icon

Ardsley Advisory Partners’s Guardant Health GH Stock Holding History

Ardsley Advisory Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-165,000
Closed -$8.88M – 134
2022
Q3 		$8.88M Buy
165,000
+54,300
+49% +$2.79M 1.99% 17
2022
Q2 		$4.47M Buy
+110,700
New +$5.48M 0.73% 38
2020
Q1 		– Sell
-326,250
Closed -$25.5M – 131
2019
Q4 		$25.5M Buy
326,250
+246,250
+308% +$17.7M 4.07% 8
2019
Q3 		$5.11M Buy
+80,000
New +$7.05M 1.15% 24

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ardsley Advisory Partners's GH Position: Q4 2022 in Review

Ardsley Advisory Partners sold out of Guardant Health (GH) in Q4 2022, closing a stake of 165,000 shares — an estimated $8.88M sold.

Ardsley Advisory Partners first reported a position in GH in Q3 2019 and held it in 4 quarters. The position peaked at $25.5M in Q4 2019. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Ardsley Advisory Partners reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Ardsley Advisory Partners sold 165,000 Guardant Health shares in Q4 2022, an estimated $8.88M.
  • Ardsley Advisory Partners first reported a position in Guardant Health in Q3 2019 and held it in 4 quarters.
  • Ardsley Advisory Partners's Guardant Health position peaked at $25.5M in Q4 2019.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Ardsley Advisory Partners's 13F filing for Q4 2022, filed 14 Feb 2023.